Sei Investments Co. trimmed its position in athenahealth, Inc (NASDAQ:ATHN) by 0.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 127,543 shares of the health services provider’s stock after selling 647 shares during the period. Sei Investments Co. owned approximately 0.32% of athenahealth worth $16,968,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. The Manufacturers Life Insurance Company lifted its holdings in shares of athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares in the last quarter. Ameriprise Financial Inc. bought a new stake in shares of athenahealth in the second quarter valued at about $206,000. Verition Fund Management LLC bought a new stake in shares of athenahealth in the second quarter valued at about $272,000. Lakeview Capital Partners LLC bought a new stake in shares of athenahealth in the fourth quarter valued at about $295,000. Finally, Quantbot Technologies LP bought a new stake in shares of athenahealth in the third quarter valued at about $337,000.
A number of brokerages have recently commented on ATHN. Piper Jaffray Companies restated a “buy” rating and issued a $160.00 price target on shares of athenahealth in a report on Friday. BidaskClub upgraded athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday. Royal Bank of Canada set a $141.00 price target on athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. SunTrust Banks boosted their price target on athenahealth to $180.00 and gave the company a “buy” rating in a report on Monday, February 5th. Finally, Canaccord Genuity boosted their price target on athenahealth from $123.00 to $137.00 and gave the company a “hold” rating in a report on Thursday, February 1st. Three investment analysts have rated the stock with a sell rating, sixteen have given a hold rating and seven have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $144.23.
athenahealth, Inc (NASDAQ ATHN) opened at $138.82 on Tuesday. The firm has a market capitalization of $5,566.38, a P/E ratio of 82.14, a price-to-earnings-growth ratio of 2.93 and a beta of 1.35. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth, Inc has a 12-month low of $95.01 and a 12-month high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. The firm had revenue of $329.20 million for the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The business’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.62 earnings per share. equities analysts forecast that athenahealth, Inc will post 2.29 EPS for the current year.
In other athenahealth news, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $132.97, for a total transaction of $106,376.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amy Abernethy sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, December 26th. The stock was sold at an average price of $134.18, for a total value of $67,090.00. Following the transaction, the director now directly owns 4,045 shares in the company, valued at approximately $542,758.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 97,903 shares of company stock worth $13,383,150. Company insiders own 3.20% of the company’s stock.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.